Abstract
The Year in Surgical Thyroidology review at the 2024 Annual Meeting of the American Thyroid Association highlights key advancements in surgical thyroidology from September 1, 2023, to August 31, 2024. This review employed a structured methodology, including a PUBMED search using MESH and keyword terms, journal analyses, and expert surveys. The selected studies cover five critical areas: non-surgical treatment of thyroid disease, quality of life (QoL), pediatric thyroid surgery, intraoperative nerve monitoring, and the parathyroid’s role in thyroid surgery. Key findings include the limited efficacy of thermal ablation retreatment for benign nodules, its potential success for indeterminate nodules, and its long-term efficacy for small papillary thyroid carcinomas (PTCs). Notably, patients with small PTCs report no significant difference in regret between active surveillance and surgery. Total thyroidectomy is associated with some reduced QoL compared to hemithyroidectomy, particularly in the early postoperative period. Additionally, routine radioactive iodine (RAI) treatment may not be necessary for pediatric PTC patients. In intraoperative nerve monitoring, loss of signal on the first side may warrant a more cautious surgical approach. Finally, promising advancements in hypoparathyroidism treatment include allotransplantation with immunosuppression, offering new hope for affected patients. These findings contribute to evolving best practices in surgical thyroidology and patient-centered care.
Author Disclosures:
The author has no multiplicity of interest to disclose.
Runtime of video: 27 mins 05 secs.
Get full access to this article
View all access options for this article.